| 101852-2 | Fluorometholone (Urine) | DRUG/TOX |
| 101853-0 | Fluticasone propionate (Urine) | DRUG/TOX |
| 101854-8 | Megestrol acetate (Urine) | DRUG/TOX |
| 101855-5 | Methylprednisolone (Urine) | DRUG/TOX |
| 101856-3 | prednisoLONE (Urine) | DRUG/TOX |
| 101857-1 | predniSONE (Urine) | DRUG/TOX |
| 101858-9 | Triamcinolone acetonide (Urine) | DRUG/TOX |
| 101859-7 | Triamcinolone (Urine) | DRUG/TOX |
| 10186-5 | Identifying information Narrative Observed | H&P.HX |
| 101860-5 | 4F-MDMB-BUTICA (Urine, confirmatory method) | DRUG/TOX |
| 101861-3 | 4F-MDMB-BUTICA/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 101862-1 | 4F-MDMB-BUTICA (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 101863-9 | Complement factor H Ab (Serum Or Plasma, immunoassay) | HEM/BC |
| 101864-7 | Oxygen/Total gas setting ECMO device | PULM |
| 101865-4 | Troponin T. cardiac 2H and 6H 5th generation panel (high sensitivity method) | PANEL.CHEM |
| 101866-2 | Gas and electrolytes point of care panel - Venous blood | PANEL.CHEM |
| 101867-0 | Ma2 Antibody (CSF, qualitative, immunoassay) | SERO |
| 101868-8 | Ma2 Antibody (qualitative, immunoassay) | SERO |
| 10187-3 | Review of systems Narrative - Reported | H&P.HX |
| 101870-4 | GABAAR IgG Ab (CSF, cell binding immunofluorescent assay) | SERO |
| 101871-2 | IgLON5 IgG Ab (CSF, cell binding immunofluorescent assay) | SERO |
| 101872-0 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab (CSF, cell binding immunofluorescent assay) | SERO |
| 101873-8 | Metabotropic glutamate receptor 1 IgG Ab (CSF, cell binding immunofluorescent assay) | SERO |
| 101874-6 | GABAAR IgG Ab (qualitative, cell binding immunofluorescent assay) | SERO |
| 101875-3 | GABAAR IgG Ab (cell binding immunofluorescent assay) | SERO |
| 101876-1 | IgLON5 IgG Ab (cell binding immunofluorescent assay) | SERO |
| 101877-9 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab (cell binding immunofluorescent assay) | SERO |
| 101878-7 | Metabotropic glutamate receptor 1 IgG Ab (cell binding immunofluorescent assay) | SERO |
| 101879-5 | Osmolality (Arterial Blood, calculated by sum of electrolytes) | CHEM |
| 10188-1 | Review of systems overview Narrative - Reported | H&P.HX |
| 101880-3 | Osmolality (Venous Blood, calculated by sum of electrolytes) | CHEM |
| 101881-1 | Implant card | DOC.ONTOLOGY |
| 101884-5 | Healthcare navigator Repository Initial evaluation note | DOC.ONTOLOGY |
| 101885-2 | Child and adolescent psychiatry Education note | DOC.ONTOLOGY |
| 101886-0 | General medicine Telephone encounter Consult note | DOC.ONTOLOGY |
| 101887-8 | Surgery Telephone encounter Consult note | DOC.ONTOLOGY |
| 101888-6 | Palliative care Telephone encounter Consult note | DOC.ONTOLOGY |
| 101889-4 | Medical Aid in Dying Discharge summary | DOC.ONTOLOGY |
| 10189-9 | Review of systems overview - Reported | H&P.HX |
| 101890-2 | Medical toxicology Discharge summary | DOC.ONTOLOGY |
| 101891-0 | Rapid response team Discharge summary | DOC.ONTOLOGY |
| 101892-8 | Occupational medicine Progress note | DOC.ONTOLOGY |
| 101893-6 | Physical medicine and rehab Letter | DOC.ONTOLOGY |
| 101894-4 | Cardiology Letter | DOC.ONTOLOGY |
| 101895-1 | Kinesiotherapy Progress note | DOC.ONTOLOGY |
| 101896-9 | Heart failure+Transplant cardiology procedure note | DOC.ONTOLOGY |
| 101897-7 | Kinesiotherapy procedure note | DOC.ONTOLOGY |
| 101898-5 | Interdisciplinary Progress note | DOC.ONTOLOGY |
| 101899-3 | Osteopathic medicine Progress note | DOC.ONTOLOGY |
| 1019-9 | E Ag on Red Blood Cells from Blood product unit (qualitative) | BLDBK |